The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment patterns and comorbidities in a population-based cohort of glioblastoma patients diagnosed 1997-2008.
Susan A. Oliveria
Research Funding - Genentech
Laura Chu
Employment or Leadership Position - Genentech
Deborah Casso
Research Funding - Genentech
Karen Wells
No relevant relationships to disclose
Wei Dong
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche
Robert Dubrow
No relevant relationships to disclose
Asha Das
Employment or Leadership Position - Genentech
Stock Ownership - Roche
David R Nerenz
No relevant relationships to disclose
Marianne Ulcickas Yood
Research Funding - Genentech